Unhide Project A Long-Term Digital Study Collecting Health and Lifestyle Data
From Individuals With Brain Inflammation and Related Conditions, and Healthy Controls
Led by Brain Inflammation Collaborative · Updated on 2026-01-22
10000
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting the unhide Project, a long-term, non-interventional study that collects health and lifestyle data from individuals aged 2 years and older in the United States. The study focuses on people with brain inflammation and related neuroinflammatory conditions, as well as healthy individuals, aiming to better understand disease types, causes, diagnostics, and potential treatments. The Brain Inflammation Collaborative sponsors this research using a secure digital platform developed to gather comprehensive health profiles over time.
Participants provide information remotely through the MyDataHelps app, branded as unhide for this study. No treatments or interventions are given as part of the study. Data collection includes self-reported health status, medical history, symptom tracking, and biometric data such as heart rate, sleep, and activity. The study follows participants for 10 or more years, with assessments occurring every 4 to 12 weeks for most measures and yearly for demographic updates.
During the study, participants will regularly complete surveys and symptom diaries via the app, enabling continuous monitoring of their health and lifestyle. Researchers will analyze phenotypic data, disease subtypes, comorbidities, quality of life, and functional status over time. This extensive data collection helps identify patterns and supports future research into neuroinflammatory diseases. The studys long duration allows for ongoing observation and potential identification of candidates for future research opportunities.
CONDITIONS
Brief Title
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Research Team
M
Megan L Fitzgerald, PhD
C
Christina Moon
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Individuals diagnosed or self-identifying with infection-associated, neuroimmune, autoimmune, inflammatory gastrointestinal, or behavioral/mood disorders
Healthy individuals without brain inflammation, including unaffected family members
Ability to participate in English
Consistent internet access and use of a smartphone, tablet, or computer
Willingness to share symptom and health data through the study platform
You will not qualify if you...
Living outside the United States
Wards of the state
Individuals with decisional impairment preventing informed consent or participation
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (remote)
Long-term Monitoring
Duration - Up to 10 years or more
Participants provide self-reported health information, biometric data, and symptom data remotely through a secure digital platform to create comprehensive longitudinal health profiles.
Assessments approximately every 4 to 12 weeks, with some assessments annually
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Study of Balance, Gait, and Motion Analysis in Adults with Multiple Sclerosis Using Vicon System
Validating Patient-Collected Selfie Videos to Measure Function in Multiple Sclerosis
Comparison of 3D Optimized WMN MPRAGE and Conventional MRI Sequences for Detecting Spinal Cord Lesions in Adults with Multiple Sclerosis
PETCT Scan with 68Ga-FAPI-46 to Detect Fibrostenosis in Small Bowel Crohns Disease
A Case-Control Study on Fibrosis Development
Evaluating a Brief Case Management Intervention to Support Personal Recovery and Reduce Involuntary Psychiatric Readmissions
Safety and Efficacy Study of CAR NK Cell Injections for RelapsedRefractory B-cell Autoimmune Diseases
Study of CD19BCMA-targeted CAR-T Therapy to Assess Safety and Early Effectiveness
in Adults with Hard-to-Treat Autoimmune Diseases
Exploratory Study of Single Infusion YTS109 Cell Therapy in Adults With Relapsed or Refractory Autoimmune Diseases
First-in-Human Study to Evaluate Safety, Tolerability, and Drug Behavior of MK-8644 in Healthy Adults and Patients With Mild to Moderate Plaque Psoriasis
Evaluating TQH3906 Capsules for Adults With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind Study Comparing TQH3906, Deucravacitinib, and Placebo
Including an Open-Label Extension Phase
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The Facilitation of Clinical and Therapeutic Discoveries in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Related Diseases: Protocol for the You + ME Registry Research Platform.